Latest News

Tesla bear sees a 50% plunge in the stock

0

S&P Futures

3,646.75

-14.25(-0.39%)

 

Dow Futures

29,143.00

-60.00(-0.21%)

 

Nasdaq Futures

11,246.25

-87.50(-0.77%)

 

Russell 2000 Futures

1,665.70

-2.70(-0.16%)

 

Crude Oil

79.11

+0.61(+0.78%)

 

Gold

1,635.30

-0.90(-0.05%)

 

Silver

18.18

-0.16(-0.86%)

 

EUR/USD

0.9577

-0.0021(-0.22%)

 

10-Yr Bond

3.9640

0.0000(0.00%)

 

Vix

33.45

+1.19(+3.69%)

 

GBP/USD

1.0685

-0.0046(-0.42%)

 

USD/JPY

144.5620

-0.2290(-0.16%)

 

BTC-USD

19,049.28

-1,204.23(-5.95%)

 

CMC Crypto 200

434.92

-24.22(-5.27%)

 

FTSE 100

6,940.32

-44.27(-0.63%)

 

Nikkei 225

26,173.98

-397.89(-1.50%)

 

One of the biggest Tesla bears on Wall Street is sticking with his views as rising global recession risks place potential pressure on the EV maker’s top and bottom lines.

Citi’s Itay Michaeli maintained a sell rating on Tesla shares in a note out on Wednesday. Shares fell more than 2% in pre-market trading.

Tesla’s stock has been shrugging off the global economic concerns hammering markets, with shares of the EV maker up more than 20% in the last three months while the S&P 500 dropped nearly 5%.

The relative out-performance reflects optimism around new government legislation that will support the adoption of EVs in 2023 and beyond. Tesla’s strong execution in the first two quarters of the year has also improved investor sentiment on the stock, which took a slight hit in August amid a broader market pullback.

Michaeli thinks otherwise, however. Here are the details behind his call:

Price Target: $141.33 (reiterated)

Rating: Sell (reiterated)

Stock price movement assumed: -50%

Michaeli is marking down his third quarter production estimates on Tesla and highlights the potential for a disappointing fourth quarter from Tesla as economic pressures mount.

“We now estimate Q3 deliveries at 369.8k units (398.5k prior) largely reflecting the production ramp at Shanghai. Our estimated Q3 deliveries incorporate strong demand but also some cushion for timing-related production/delivery variances. Given a number of production ramps this quarter and heavy reliance on September volume, there could be greater variance than usual in the Q3 delivery numbers. With production continuing to ramp into Q4, our 2022 deliveries estimate is intact (~1.4 million) since we regard the Q3 delta (vs. our initial estimate) as largely timing related. That said, we view the macro situation (particularly in Europe) as posing some risk to Q4 numbers.”

Visitors look at a Tesla model during the 5th China International Industrial Design Expo in Wuhan International Expo Center on August 5,2022 in Wuhan, Hubei Province, China. (Photo by Getty Images)

Tesla shares continue to be overvalued, Michaeli argues.

“Our view is based on a risk/reward assessment, blending likely EV and AV/software outcomes. We currently believe that future bull case expectations appear too aggressive (Tesla selling ~20mln units by ~2030 & soon achieving L4 RoboTaxi leadership), based on key data points we’re tracking. We are constructive on Tesla’s strong EV position and particularly the company’s improved execution in recent years. However, we are more skeptical on the company’s FSD/AV approach, which we view as a critical input to the overall risk/reward assessment given our positive stance on the AV opportunity as a whole.”

Michaeli listed a few factors that may prompt an upgrade on Tesla’s stock.

“If we began seeing signs that demand is consistent with the current narrative.

If Tesla’s margin performance (ex. credits) experienced a meaningful and sustainable expansion, then that would be supportive of a lasting competitive advantage.

New product announcements related to Car of the Future (Model Y, etc).

Given the industry’s race for Car of the Future TAMs, the potential of partnering or even being acquired by a large Tech company looking to enter future TAMs that we believe exist in mobility services.

If remaining/recent legal investigations turn out more favorably.

If the impact from the above risks turns out to be greater than we anticipate, the shares could exceed our target price.”

Brian Sozzi is an editor-at-large and anchor at Yahoo Finance. Follow Sozzi on Twitter @BrianSozzi and on LinkedIn.

Click here for the latest trending stock tickers of the Yahoo Finance platform

Click here for the latest stock market news and in-depth analysis, including events that move stocks

Read the latest financial and business news from Yahoo Finance

Download the Yahoo Finance app for Apple or Android

Follow Yahoo Finance on Twitter, Facebook, Instagram, Flipboard, LinkedIn, and YouTube

Advertisement

Bloomberg

Dollar Rallies, UK Bonds Surge After BOE Statement: Markets Wrap

(Bloomberg) — The dollar rose to another record after the White House talked down the prospect of weakening the currency, while UK bonds surged after the Bank of England said it would carry out temporary purchases of long-dated government bonds to help restore order to the market.US futures were mixed, while European stocks dropped for a fifth day as investors abandon the region at levels last seen during the euro area debt crisis, according to Citigroup Inc. strategists. Asian shares fell.Heal

Bloomberg

Apple Ditches iPhone Production Increase After Demand Falters

(Bloomberg) — Apple Inc. is backing off plans to increase production of its new iPhones this year after an anticipated surge in demand failed to materialize, according to people familiar with the matter.The Cupertino, California-based electronics maker has told suppliers to pull back from efforts to increase assembly of the iPhone 14 product family by as many as 6 million units in the second half of this year, said the people, asking not to be named as the plans are not public. Instead, the com

TheStreet.com

Warren Buffett’s Berkshire Makes List of Undervalued,  Stocks

The CBOE Volatility Index has skyrocketed 89% so far this year. Morningstar put together a list of stocks with one- and three-year betas of 0.8 or lower. Then it screened for stocks that are undervalued, according to Morningstar analysts’ fair value estimates.

Reuters

Futures drop after report on Apple slowing iPhone production sparks selloff

Shares of the world’s most valuable public company fell 3.6% after Bloomberg reported that Apple had told suppliers to curtail efforts to increase assembly of its flagship iPhone 14 product family by as many as 6 million units in the second half of this year. Other megacap growth names such as Amazon.com Inc, Microsoft Corp, Meta Platforms Inc and Tesla Inc fell between 0.8% and 1.2% in premarket trading with U.S. 10 year bond yields back at their highest since 2010. Chipmakers Advanced Micro Devices, Qualcomm Inc Nvidia Corp and Micron Tech fell between 1.6% and 2.5%.

Reuters

Fed to take rates higher than previously expected; more pain ahead – Reuters poll

The Federal Reserve will hike its key interest rate to a much higher peak than predicted two weeks ago and the risks are skewed towards an even higher terminal rate, according to economists polled by Reuters. That change in expectations came after the Fed raised rates by 75 basis points last week for the third straight meeting and foresaw going higher than it had previously thought to tame inflation, which is running over four times above target. Since then, already battered global stocks went much deeper into bear market territory – a decline of 20% or more – on fears of recession and most currencies weakened further against the multi-decade high dollar.

Yahoo Life UK

Who is Carrie Johnson and how long has she been with Boris?

Here’s the lowdown on Carrie, wife of Boris Johnson, including her education, children and career.

Yahoo Finance

Stocks trending after hours: Goldman Sachs, Lyft, Mind Medicine and more

Big banks, Mind Medicine, and Lyft are among the top trending stocks on Yahoo Finance on Tuesday, September 27, 2022.

Reuters

Marketmind: Gimme Shelter

As the final quarter of an unremittingly dire year for world markets hoves into view, stocks and bonds have now cratered to new lows as central banks keep talking tough and debt strains mount across major economies. The blowup in British bonds and sterling remains the epicentre of this week’s storm, with global credit rating firms and the International Monetary Fund lambasting UK government tax-slashing plans as incoherent in fighting inflation and a risk to debt sustainability that lifts inequality. Even U.S. Treasury Secretary Janet Yellen said she was monitoring developments in the UK, though she added that financial markets were “still functioning well” with no liquidity problems yet.

Reuters

Biogen, Eisai stocks soar on landmark Alzheimer’s data, lifting rivals

Shares in Biogen and Eisai soared on Wednesday reflecting the surprise trial success of their experimental Alzheimer’s drug, which also lifted the stocks of rival drugmakers Roche and Eli Lilly. Against the odds, Biogen and Eisai on Tuesday said their experimental drug, lecanemab, slowed progress of the brain-wasting disease by 27% compared with a placebo, in a large trial of patients in the early stages of Alzheimer’s. The data is an “unequivocal win” for Alzheimer’s patients and Biogen, said BMO analyst Evan Seigerman.

Reuters

Elon Musk seeks to narrow SEC consent decree, end pre-approval of tweets

NEW YORK (Reuters) -Elon Musk’s lawyers urged a federal appeals court to throw out a provision in his 2018 consent decree with the U.S. Securities and Exchange Commission (SEC) requiring a Tesla Inc lawyer to vet some of his posts on Twitter. In a brief filed late on Tuesday with the 2nd U.S. Circuit Court of Appeals in Manhattan, lawyers for Musk called the pre-approval mandate a “government-imposed muzzle” that inhibited and chilled his lawful speech on a broad range of topics. The SEC did not immediately respond to a request for comment outside market hours.

MarketWatch

Medicare premiums are decreasing in 2023 – this is how much older Americans will save if they’re on Part B

Medicare beneficiaries will see their Part B premiums go down for the first time in more than a decade, President Biden said during a press conference on Tuesday. Monthly Part B premiums, which are currently set at $170.10 in 2022, will decline to $164.90 in 2023 – a $5.20 a month savings, or about $64 a year, according to the Centers for Medicare and Medicaid Services. The annual deductible for Part B will be $226, down $7 from $233 in 2022.

Apple Ditches iPhone Production Increase After Demand Falters

Previous article

Dow Jones Futures Volatile On Bank Of England Reversal; Apple Falls On iPhone Report, Biogen Soars On Alzheimer’s Drug

Next article

You may also like

Comments

Leave a reply

Your email address will not be published. Required fields are marked *

More in Latest News